HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 172 filers reported holding HAEMONETICS CORP in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $5,922,000 | +6.8% | 169,300 | -1.6% | 2.28% | +3.0% |
| Q4 2015 | $5,545,000 | -13.4% | 172,000 | -13.2% | 2.22% | -0.7% |
| Q3 2015 | $6,404,000 | -22.8% | 198,150 | -1.2% | 2.23% | -12.9% |
| Q2 2015 | $8,299,000 | -53.5% | 200,650 | -49.5% | 2.56% | +5.0% |
| Q1 2015 | $17,862,000 | +16.5% | 397,650 | -2.9% | 2.44% | +19.5% |
| Q4 2014 | $15,329,000 | +4.9% | 409,650 | -2.1% | 2.04% | -1.2% |
| Q3 2014 | $14,616,000 | -4.3% | 418,550 | -3.3% | 2.07% | +8.7% |
| Q2 2014 | $15,278,000 | +6.2% | 433,050 | -1.9% | 1.90% | +6.6% |
| Q1 2014 | $14,380,000 | -24.6% | 441,250 | -2.5% | 1.78% | -23.9% |
| Q4 2013 | $19,060,000 | -13.0% | 452,400 | -17.6% | 2.34% | +4.1% |
| Q3 2013 | $21,902,000 | -5.3% | 549,200 | -1.8% | 2.25% | -12.2% |
| Q2 2013 | $23,127,000 | – | 559,300 | – | 2.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bridge City Capital, LLC | 40,541 | $5,114,000 | 2.20% |
| Lisanti Capital Growth, LLC | 53,385 | $6,734,000 | 2.20% |
| Nitorum Capital, L.P. | 279,510 | $35,257,000 | 2.05% |
| CROWN ADVISORS MANAGEMENT, INC. | 20,000 | $2,523,000 | 1.69% |
| Millrace Asset Group, Inc. | 11,400 | $1,438,000 | 1.69% |
| COOKSON PEIRCE & CO INC | 145,884 | $18,402,000 | 1.61% |
| Endurant Capital Management LP | 32,594 | $4,111,000 | 1.48% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 111,000 | $14,002,000 | 1.38% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 110,065 | $13,884,000 | 1.37% |
| EMERALD ADVISERS, LLC | 203,640 | $25,687,000 | 1.20% |